PayerPrice
Data Platform
Sign InTry for Free
Blue Cross Blue Shield logo

Blue Cross Blue Shield Lab & Pathology

Compare Blue Cross Blue Shield's contracted rates for lab & pathology services against national averages and other major payers. Use these benchmarks to identify underpaid codes, prepare for contract renegotiations, and validate your reimbursement strategy.

BCBS rates vary substantially across the 30+ independent BCBS plans nationwide. State-by-state market dynamics and local provider negotiation drive significant pricing differences within the same specialty.

Introduction

Laboratory reimbursement is governed by the Clinical Laboratory Fee Schedule (CLFS) for Medicare and individually negotiated rates for commercial payers. The Protecting Access to Medicare Act (PAMA) tied Medicare lab rates to weighted median commercial rates, making payer contract benchmarking more critical than ever for hospital labs and reference laboratories.

Lab services are billed using CPT codes organized by discipline — chemistry, hematology, microbiology, anatomic pathology, and molecular diagnostics — with reimbursement varying widely between reference laboratories, hospital outpatient labs, and physician office labs. High-volume tests like CBC and metabolic panels drive aggregate revenue even at low per-test rates, while molecular and specialty testing carries the widest payer-to-payer variation.


Chemistry & Metabolic Panels

Organ & Disease Panels

Bundled chemistry panels that measure multiple analytes in a single test. Panels are among the highest-volume lab tests ordered across inpatient and outpatient settings. Payer reimbursement for panels varies significantly and is a key contract term for reference laboratories.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
80053Comprehensive Metabolic Panel This Panel Must Include The Following: Albumin (82040) Bilirubin, Total (82247) Calcium, Total (82310) Carbon Dioxide (Bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Phosphatase, Alkaline (84075) Potassium (840301Laboratory - chemistry
80048Basic Metabolic Panel (Calcium, Total) This Panel Must Include The Following: Calcium, Total (82310) Carbon Dioxide (Bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea Nitrogen (Bun) (84520)0301Laboratory - chemistry
80061Lipid Panel This Panel Must Include The Following: Cholesterol, Serum, Total (82465) Lipoprotein, Direct Measurement, High Density Cholesterol (Hdl Cholesterol) (83718) Triglycerides (84478)0301Laboratory - chemistry
80076Hepatic Function Panel This Panel Must Include The Following: Albumin (82040) Bilirubin, Total (82247) Bilirubin, Direct (82248) Phosphatase, Alkaline (84075) Protein, Total (84155) Transferase, Alanine Amino (Alt) (Sgpt) (84460) Transferase, Aspartate Amino (Ast)0301Laboratory - chemistry

Endocrine & Metabolic Tests

Individual chemistry tests for thyroid function, diabetes management, nutritional status, and metabolic evaluation. These are high-frequency tests with wide variation in commercial payer reimbursement.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
84443Thyroid Stimulating Hormone (Tsh) 0301Laboratory - chemistry
83036Hemoglobin Glycated 0301Laboratory - chemistry
82306Vitamin D; 25 Hydroxy, Includes Fraction(S), If Performed0301Laboratory - chemistry
82607Cyanocobalamin (Vitamin B-12) 0301Laboratory - chemistry

Cardiac & Inflammatory Markers

Chemistry tests used in emergency and inpatient settings for cardiac evaluation, inflammatory conditions, and risk stratification. Troponin and BNP are critical ED decision-making tests.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
84484Troponin 0301Laboratory - chemistry
83880Natriuretic Peptide 0301Laboratory - chemistry
86140C-Reactive Protein 0301Laboratory - chemistry
82553Creatine Kinase (Ck/Cpk) Mb Fract 0301Laboratory - chemistry

Hematology & Coagulation

Hematology

Complete blood count and related hematologic tests. CBC with differential is the single most frequently ordered lab test in U.S. hospitals and outpatient practices, making it a significant line item in lab payer contracts.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
85025Complete Blood Cell Count (Red Cells, White Blood Cell, Platelets), Automated Test And Automated Differential White Blood Cell Count0305Laboratory - hematology
85027Blood Count; Complete (Cbc) Automated (Hgb Hct Rbc Wbc And Platelet Count) (Desc Rev 1/1/03)0305Laboratory - hematology
85652Red Blood Cell Sedimentation Rate, To Detect Inflammation, Automated0305Laboratory - hematology
85044Blood Count;Reticulocyte Cnt,Manual 0305Laboratory - hematology

Coagulation Studies

Tests for blood clotting function including PT/INR for warfarin management, PTT for heparin monitoring, and D-dimer for DVT/PE workup. High-volume in both inpatient anticoagulation management and outpatient monitoring.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
85610Prothrombin Time; 0305Laboratory - hematology
85730Thromboplast Time,Part.(Ptt);Plasma/Whol 0305Laboratory - hematology
85379Fibrin Degradat Prod D-Dimer Quan 0305Laboratory - hematology
85670Thrombin Time; Plasma 0305Laboratory - hematology

Microbiology & Infectious Disease

Cultures

Bacterial and fungal culture tests for identifying infectious organisms. Blood and urine cultures are among the most commonly ordered microbiology tests in hospital settings, with significant reimbursement variation between rapid and standard methods.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
87040Culture Bacterial; Blood Aerobic With Isolation And Presumptive Identification Of Isolates (Includes Anaerobic Culture If Appropriate) (Rvsd 1/1/04)0306Laboratory - bacteriology & microbiology
87045Culturre, Bacterial, Definitive; Stool, Aerobic, With Isolation And Preliminary Examination, (Eg, Kia, Lia), Salmonella And Shigella Species0306Laboratory - bacteriology & microbiology
87070Culture Bacterial; Any Other Source Except Urine Blood Or Stool Aerobic With Isolation And Presumptive Identification Of Isolates (Rvsd 1/1/04)0306Laboratory - bacteriology & microbiology
87086Culture, Bacterial, Urine; Quantitative, Colony Count,Urine0306Laboratory - bacteriology & microbiology

Molecular & NAAT Testing

Nucleic acid amplification tests (NAAT) for infectious disease detection including STIs, respiratory pathogens, and GI panels. Molecular testing reimbursement is among the most variable across payers, with wide gaps between contracted and out-of-network rates.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
87491Nucleic Acid Detection; Chlamydia Trachomatis, By Amplified Probe 0306Laboratory - bacteriology & microbiology
87591Nucleic Acid Detection; Neisseria Gonorrhoeae, By Amplified Probe 0306Laboratory - bacteriology & microbiology
87631Infectious Agent Detection By Nucleic Acid (Dna Or Rna); Respiratory Virus (Eg Adenovirus Influenza Virus Coronavirus Metapneumovirus Parainfluenza Virus Respiratory Syncytial Virus Rhinovirus) Includes Multiplex Reverse Transcrip-Tion When Performed And Multiplex Amplified Probe Technique Multiple Types Or Subtypes 3-5 Types (Desc Revised 01/01/15)0306Laboratory - bacteriology & microbiology
87635(Infectious Agent Detection By Nucleic Acid (Dna Or Rna); Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Coronavirus Disease [Covid-19] Amplified Probe Technique.0306Laboratory - bacteriology & microbiology

Rapid & Point-of-Care Testing

Rapid antigen and point-of-care tests for immediate clinical decision-making. These tests are typically reimbursed at lower rates than molecular assays but have high volume in urgent care and emergency settings.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
87804Infectious Agent Antigen Detection By Immunoassay With Direct Optical (Ie Visual) Observation; Influenza (Desc Rvsd 10/6/20)0306Laboratory - bacteriology & microbiology
87426Infectious Agent Antigen Detection By Immunoassay Technique (Eg Enzyme Immunoassay [Eia] Enzyme- Linked Immunosorbent Assay [Elisa] Fluorescence Immunoassay [Fia] Immuno- Chemiluminometric Assay [Imca]) Qualitative Or Semiquantitative; Severe Acute Respiratory Syndrome Coronavirus (Eg Sars-Cov Sars-Cov-2 [Covid-19]) (Desc Rvsd 10/6/20)0306Laboratory - bacteriology & microbiology
87880Infectious Agent Antigen Detection By Immunoassay With Direct Optical (Ie Visual) Observation; Streptococcus Group A (Desc Rvsd 10/6/20)0306Laboratory - bacteriology & microbiology
87449Infectious Agent Antigen Detection By Immunoassa Technique (Eg Enzyme Immunoassay [Eia] Enzyme Linked Immunosorbent Assay [Elisa] Fluorescence Immunoassay [Fia] Immuno- Chemiluminometric Assay [Imca]) Qualitative Or Semiquantitative; Not Otherwise Specified Each Organism (Desc Rvsd 10/6/20)0306Laboratory - bacteriology & microbiology

Urinalysis & Drug Testing

Urinalysis

Routine and microscopic urinalysis for evaluation of kidney function, urinary tract infections, and metabolic conditions. Urinalysis is a high-volume, low-cost test that is often bundled in inpatient billing.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
81001Urinalysis, By Dip Stick Or Tablet Reagent For Bilirubin, Glucose, Hemoglobin, Ketones, Leukocytes, Nitrite, Ph, Protein, Specific Gravity, Urobilinogen, Any Number Of These Constituents; Automated, With Microscopy0307Laboratory - urinalysis
81003Urinalysis, By Dip Stick Or Tablet Reagent For Bilirubin, Glucose, Hemoglobin, Ketones, Leukocytes, Nitrite, Ph, Protein, Specific Gravity, Urobilinogen, Any Number Of These Constituents; Automated, Without Microscopy0307Laboratory - urinalysis
81015Urinalysis Microscopic Onlyur0307Laboratory - urinalysis

Drug Screening & Confirmation

Presumptive and definitive drug testing used in pain management, substance use treatment, pre-employment, and compliance monitoring. Drug testing reimbursement has been under increased payer scrutiny with many plans implementing frequency limits and prior authorization requirements.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
80305Drug Test(S) Presumptive Any Number Of Drug Classes Any Number Of Devices Or Procedures; Capable Of Being Read By Direct Optical Observation Only (Eg Utilizing Immunoassay [Eg Dipsticks Cups Cards Or Cartridges]) Includes Sample Validation When Performed Per Date Of Service (Desc Revised 1/1/2018)0301Laboratory - chemistry
80306Drug Test(S) Presumptive Any Number Of Drug Classes Any Number Of Devices Or Procedures; Read By Instrument Assisted Direct Optical Observation (Eg Utilizing Immunoassay [Eg Dipsticks Cups Cards Or Cartridges]) Includes Sample Validation When Performed Per Date Of Service (Desc Revised 1/1/2018)0301Laboratory - chemistry
80307Drug Test(S) Presumptive Any Number Of Drug Classes Any Number Of Devices Or Procedures; By Instrument Chemistry Analyzers (Eg Utilizing Immunoassay [Eg Eia Elisa Emit Fpia Ia Kims Ria]) Chromatography (Eg Gc Hplc) And Mass Spectrometry Either With Or Without Chromatography(Eg Dart Desi Gc-Ms Gc-Ms/Ms Lc-Ms Lc-Ms/Ms Ldtd Maldi Tof) Includes Sample Validation When Performed Per Date Of Service (Desc Revised 1/1/2018)0301Laboratory - chemistry
G0480Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed0301Laboratory - chemistry

Anatomic Pathology

Surgical Pathology

Tissue examination and diagnosis from biopsies and surgical specimens. Surgical pathology reimbursement is tiered by specimen complexity (levels 1-6), with significant payer variation at the higher complexity levels that involve intraoperative consultation and immunohistochemistry.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
88305Level Iv - Surgical Pathology, Gross And Microscopic Examination Abortion - Spontaneous/Missed Artery, Biopsy Bone Marrow, Biopsy Bone Exostosis Brain/Meninges, Other Than For Tumor Resection Breast, Biopsy, Not Requiring Microscopic Evaluation Of Surgical Margins0314Laboratory - histology
88304Level Iii - Surgical Pathology, Gross And Microscopic Examination Abortion, Induced Abscess Aneurysm - Arterial/Ventricular Anus, Tag Appendix, Other Than Incidental Artery, Atheromatous Plaque Bartholin S Gland Cyst Bone Fragment(S), Other Than Pathologic Fracture0314Laboratory - histology
88307Level V - Surgical Pathology, Gross And Microscopic Examination Adrenal, Resection Bone - Biopsy/Curettings Bone Fragment(S), Pathologic Fracture Brain, Biopsy Brain/Meninges, Tumor Resection Breast, Excision Of Lesion, Requiring Microscopic Evaluation Of Surgical0314Laboratory - histology
88309Level Vi - Surgical Pathology, Gross And Microscopic Examination Bone Resection Breast, Mastectomy - With Regional Lymph Nodes Colon, Segmental Resection For Tumor Colon, Total Resection Esophagus, Partial/Total Resection Extremity, Disarticulation Fetus, With Diss0314Laboratory - histology

Cytopathology

Cell-level examination including Pap smears and fine needle aspiration cytology. Pap smear reimbursement has been relatively stable but varies by screening vs. diagnostic indication and whether the test is physician-interpreted or auto-screened.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
88175Cytopathology, Cervical Or Vaginal (Any Reporting System), Collected In Preservative Fluid, Automated Thin Layer Preparation; With Screening By Automated System And Manual Rescreening Or Review, Under Physician Supervision0311Laboratory - cytology
88112Cytopathology, Selective Cellular Enhancement Technique With Interpretation (Eg, Liquid Based Slide Preparation Method), Except Cervical Or Vaginal0311Laboratory - cytology
88108Cytopathology, Fluids, Washings Or Brushings, With Centrifugation Except Cervical Or Vaginal; Concentration Techniq0311Laboratory - cytology

Specimen Collection

Phlebotomy & Specimen Handling

Venipuncture and capillary blood collection services. While individually low-reimbursement, specimen collection fees represent significant aggregate revenue for reference labs and hospital outpatient departments processing thousands of draws per day.

Billing CodeDescriptionRevenue CodeDescriptionAvg. National BCBS Rate
36415Routine Venipuncture/Finger/Heel/Ear Stick, Collection, Specimen(S)0300Laboratory
36416Collection Of Capillary Blood Specimen (Eg, Finger, Heel, Ear Stick) 0300Laboratory
99000Handling And/Or Conveyance Of Specimen For Transfer From The Office To A Laboratory (Revised 01/01/13)0300Laboratory

What is a fee schedule?

A fee schedule is a list of negotiated prices that healthcare providers charge for specific services. These prices vary by payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the applicable fee schedule helps providers optimize billing for accurate reimbursement and helps patients anticipate out-of-pocket costs.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts.


Private Insurance Rates

Negotiated rates between providers and insurance companies.


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.


View lab & pathology fee schedules for other major payers

Aetna logo
United Healthcare logo
Cigna logo

What is Price Transparency?

The federal Price Transparency Rule took effect in July 2022, requiring all commercial payers to publicly disclose their prices through machine-readable files (MRFs). This landmark regulation mandates that insurance companies make healthcare costs transparent to the public. Read more here.

PayerPrice gives you access to the actual prices that insurers are legally required to publish under the Price Transparency Rule. We deliver this data exactly as reported in the insurers' machine-readable files, giving you an accurate view of negotiated rates. While insurers occasionally report incomplete or inaccurate data, our platform ensures you see the same information that insurers have made publicly available.


FREE SAMPLE MARKET COMPARISON
Let's review your payer contracts side-by-side with the market.

Bring your top codes and we'll show you how you compare in 15 minutes or less.